Dysfunction of Muscle Contraction with Impaired Intracellular Ca Handling in Skeletal Muscle and the Effect of Exercise Training in Male Db/db Mice
Overview
Authors
Affiliations
Type 2 diabetes is characterized by reduced contractile force production and increased fatigability of skeletal muscle. While the maintenance of Ca homeostasis during muscle contraction is a requisite for optimal contractile function, the mechanisms underlying muscle contractile dysfunction in type 2 diabetes are unclear. Here, we investigated skeletal muscle contractile force and Ca flux during contraction and pharmacological stimulation in type 2 diabetic model mice ( db/db mice). Furthermore, we investigated the effect of treadmill exercise training on muscle contractile function. In male db/db mice, muscle contractile force and peak Ca levels were both lower during tetanic stimulation of the fast-twitch muscles, while Ca accumulation was higher after stimulation compared with control mice. While 6 wk of exercise training did not improve glucose tolerance, exercise did improve muscle contractile dysfunction, peak Ca levels, and Ca accumulation following stimulation in male db/db mice. These data suggest that dysfunctional Ca flux may contribute to skeletal muscle contractile dysfunction in type 2 diabetes and that exercise training may be a promising therapeutic approach for dysfunctional skeletal muscle contraction. NEW & NOTEWORTHY The purpose of this study was to examine muscle contractile function and Ca regulation as well as the effect of exercise training in skeletal muscle in obese diabetic mice ( db/db). We observed impairment of muscle contractile force and Ca regulation in a male type 2 diabetic animal model. These dysfunctions in muscle were improved by 6 wk of exercise training.
Kominami K, Akino M, Kanai M Phys Ther Res. 2025; 27(3):180-185.
PMID: 39866392 PMC: 11756561. DOI: 10.1298/ptr.E10298.
Salagre D, Navarro-Alarcon M, Gonzalez L, Elrayess M, Villalon-Mir M, Haro-Lopez R Antioxidants (Basel). 2025; 14(1).
PMID: 39857351 PMC: 11762543. DOI: 10.3390/antiox14010016.
Zhang Y, Liu Y, Liu X, Yuan X, Xiang M, Liu J Oxid Med Cell Longev. 2022; 2022:2297268.
PMID: 36120597 PMC: 9481363. DOI: 10.1155/2022/2297268.
Yamamoto H, Eshima H, Kakehi S, Kawamori R, Watada H, Tamura Y Physiol Rep. 2022; 10(18):e15478.
PMID: 36117307 PMC: 9483406. DOI: 10.14814/phy2.15478.
Eshima H Front Physiol. 2021; 12:758316.
PMID: 34795598 PMC: 8592904. DOI: 10.3389/fphys.2021.758316.